Literature DB >> 34606766

Regression of aneurysmal type 1 neovascularization after brolucizumab injections.

Matteo Airaldi1, Mariano Cozzi2, Giovanni Staurenghi2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34606766     DOI： 10.1016/j.jcjo.2021.09.001

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN： 0008-4182            Impact factor:   2.592


× No keyword cloud information.
  1 in total

Review 1.  Brolucizumab for the Treatment of Degenerative Macular Conditions: A Review of Clinical Studies.

Authors:  Evdoxia-Maria Karasavvidou; Paris Tranos; Georgios D Panos
Journal:  Drug Des Devel Ther       Date:  2022-08-09       Impact factor: 4.319
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.